🇺🇸 Meropem in United States

4 US adverse-event reports

Marketing authorisation

FDA

Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Window: 27 March 2025 – 27 March 2026
Total reports: 4

Most-reported reactions

Abdominal Pain Lower — 1 report (25%)
Diarrhoea — 1 report (25%)
Dysbacteriosis — 1 report (25%)
Mucous Stools — 1 report (25%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Meropem approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Meropem in United States?

Yung Shin Pharm. Ind. Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.